期刊文献+

产OXA-23型碳青霉烯水解酶鲍曼不动杆菌基因研究 被引量:10

Studies on the isolates of Acinetobacter baumannii producing OXA-23 carbapenemase
下载PDF
导出
摘要 目的 了解临床分离 12株耐碳青霉烯鲍曼不动杆菌的耐药情况、耐药株来源以及产碳青霉烯酶的类型。方法 收集本院对碳青霉烯类药中介或耐药的鲍曼不动杆菌 12株 ,用琼脂稀释法测定最低抑菌浓度(MIC) ,脉冲场凝胶电泳 (PFGE)分析其同源性 ,并用聚合酶链反应 (PCR)检测分析其耐药基因。结果  12株细菌均为多重耐药株 ,有 9株对亚胺培南耐药 ,6株对美罗培南耐药。对青霉素类、头孢菌素类、复方磺胺甲唑均耐药 ,对氟喹诺酮类和酶抑制剂复合物耐药率最低。 12株PFGE图谱分为A、B(B1、B2 ) 2型 ,以A型为主要流行株 (9株 ) ,主要集中在重症监护病房 (ICU)。PCR检出 12株菌株均携带OXA 2 3基因 ,未能检出OXA 2 4基因。结论 本院碳青霉烯类耐药鲍曼不动杆菌流行主要为医院感染所致 ,该流行株呈多重耐药 ,12株菌株均产OXA 2 3型碳青霉烯酶。 Objective To investigate the resistance and homology of carbapenem-resistant Acinetobacter baumannii and the type of carbapenemases. Methods Twelve strains of carbapenem-intermediate and -resistant Acinetobacter baumannii isolated from clinical specimen were analyzed by pulsed-field gel electrophoresis (PFGE). Agar dilution method was made to determine the minimum inhibitory concentrations (MIC) of these strains, and the carbapenemase produced by these strains were detected by polymerase chain reaction (PCR). Results Nine strains were resistant to imipenem, but only six were resistant to meropenem. All strains were resistant to penicillin, cephalosporins, and trimethoprim/sulfamethoxazole, weakly resistant to fluoroquinolones and β-lactams. Twelve strains were classified into Type A and B (B1,B2) according to PFGE pattern. Most of type A strains were isolated from intensive care unit (ICU). Only OXA-23 type gene were detected in these twelve isolates, but no OXA-24 type gene was detected by PCR. Conclusions Carbapenem-resistant A cinetobacter baumannii is the epidemic strain in our hospital from nosocomial infection. They are multi-drug resistant. All strains can produce OXA-23 type carbapenemase.
出处 《检验医学》 CAS 北大核心 2004年第6期483-486,共4页 Laboratory Medicine
关键词 产OXA-23型碳青霉烯水解酶 鲍曼不动杆菌 基因 研究 耐药基因型 脉冲场凝胶电泳 Acinetobacter Pulsed-field gel electrophoresis Resistant genetype
  • 相关文献

参考文献9

  • 1Bergogne-Berezin E,Towner KJ.Acinetobacter spp as nosocomial pathogens: microbiological,clinical,and epidemiological features [J].Clin Microbiol Rev,1996,9:148-165.
  • 2Levi I,Rubinstein E.Acinetobacter infections-overview of clinical features.In: Bergogne-Berezin E,Joly-Guillou ML,Towner KJ.Acinetobacter microbiology,epidemiology,infections,management [M].New York: CRC press,1996.101-115.
  • 3Bou G,Cervero G,Dominguez MA,et al.Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme: high-level carbapenem resistance in A.baumannii is not due solely to the presence
  • 4National Committee for Clinical Laboratory Standards.Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically [S].Approved standard M7-A4.NCCLS Wayne,Pa,1997.
  • 5Libera M,Dalla C,Juliana M,et al.Outbreak of carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzxyme in curitiba,brazil [J].Journal of Clinical Microbiology,2003,41:3403-3406.
  • 6Afzal-Shah M,Woodford N,Livermore DM.Characterization of OXA-25,OXA-26 and OXA-27,molecular class D beta-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii [J].AAC,2001,45:583-588.
  • 7Tenover FC,Arbeit RD,Goering RV,et al.Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis; criteria for bacterial strain typing [J].J Clin Microbial,1995,33:2233-2239.
  • 8Levin AS,Levy CE,Manrique AE,et al.Severe nosocomial infections with imipenem-resistant Acinetobacter baumannii treated with ampicillin/sulbactam [J].Int J Antimicrob Agents,2003,21:58-62.
  • 9Amyes GB,Young HK.Mechanism of antibiotic resistance in Acinetobacter spp-genetics of resistance.In: Bergogne-Berezin E,Joly-Guillou ML,Towner KJ.Acinetobacter microbiology,epidemiology,infections,management [M].New York: CRC press,1996.185-223.

同被引文献99

引证文献10

二级引证文献88

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部